CVE-2025-30452

Exploitation

Assessed, none found. CISA's assessment recorded neither public exploit code nor evidence of exploitation when it was made.

SSVC decision

• ExploitationnoneCISA recorded no public exploit code and no evidence of exploitation.
• AutomatableyesAn attacker can reliably automate reconnaissance through exploitation, so this scales.
• Technical ImpacttotalSuccessful exploitation gives total control of the vulnerable component.

CISA publishes the decision points, not a final SSVC decision. The decision also depends on mission and well-being impact, which is a property of your deployment rather than of the vulnerability.

EPSS probability

1.10% probability of exploitation activity in the next 30 days.

EPSS percentile

Ranks above 63.2% of scored records. A rank, not a probability.

NVD base score

9.8 (CVSS v3.x), scored by the NVD independently of the CNA.

NVD CVSS vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

NVD analysis status

Modified. NVD last modified this record on 2026-06-17.

Red Hat severity

No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

Published

2025-03-31 22:22Z1 YR AGO

Last updated

2026-06-23 17:35Z2 MO AGO

Reserved

2025-03-22

Assigning CNA

apple

Record state

PUBLISHED

Severity

Critical (CVSS 9.8)

CNA CVSS vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Weaknesses

• CWE-20Improper Input ValidationClass

Data version

5.2

Document digest

5bf31b59ba16b58ab4066d8e2830da7653cadf6e45fa4576559d0ad558e12a1a

• support.apple.comhttps://support.apple.com/en-us/122373
• support.apple.comhttps://support.apple.com/en-us/122374
• support.apple.comhttps://support.apple.com/en-us/122375
• seclists.orghttp://seclists.org/fulldisclosure/2025/Apr/10
• seclists.orghttp://seclists.org/fulldisclosure/2025/Apr/9
• seclists.orghttp://seclists.org/fulldisclosure/2025/Apr/8